EA
OGN icon

Evolution Advisers’s Organon & Co OGN Stock Holding History

Evolution Advisers’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+27
New +$323 ﹤0.01% 676

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Evolution Advisers's OGN Position: Q2 2026 in Review

Evolution Advisers opened a new position in Organon & Co (OGN) in Q2 2026: 27 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #676 among its holdings.

627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Evolution Advisers held 27 shares of Organon & Co worth $0 as of Q2 2026.
  • Organon & Co was a new Evolution Advisers position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #676 holding.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.